ImmuCell CorporationICCCNASDAQ
Loading
Gross Profit Growth Under PressureDecelerating
Percentile Rank86
5Y CAGR+89.1%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

5Y CAGR
+89.1%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
24.2x
Strong expansion
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
202544.12%
202480.63%
2023-42.52%
2022-11.63%
202126.12%
20201.82%
201929.77%
2018-0.52%
2017-3.68%
2016-13.28%